Our top pick for
Northrim BanCorp Inc is a banks-regional business based in the US. Northrim BanCorp shares (NRIM) are listed on the NASDAQ and all prices are listed in US Dollars. Northrim BanCorp employs 438 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$44.31|
|52-week range||$27.04 - $47.36|
|50-day moving average||$42.12|
|200-day moving average||$42.51|
|Wall St. target price||$46.00|
|Dividend yield||$1.47 (3.31%)|
|Earnings per share (TTM)||$6.72|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||-0.23%|
|1 month (2021-09-21)||12.66%|
|3 months (2021-07-21)||5.95%|
|6 months (2021-04-21)||4.46%|
|1 year (2020-10-21)||47.16%|
|2 years (2019-10-21)||14.97%|
|3 years (2018-10-19)||15.93%|
|5 years (2016-10-21)||71.81%|
Valuing Northrim BanCorp stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Northrim BanCorp's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Northrim BanCorp's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, Northrim BanCorp shares trade at around 7x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Revenue TTM||$147.5 million|
|Operating margin TTM||38.84%|
|Gross profit TTM||$131.6 million|
|Return on assets TTM||1.9%|
|Return on equity TTM||19.13%|
|Market capitalisation||$273.4 million|
TTM: trailing 12 months
There are currently 40,366 Northrim BanCorp shares held short by investors – that's known as Northrim BanCorp's "short interest". This figure is 13.2% down from 46,493 last month.
There are a few different ways that this level of interest in shorting Northrim BanCorp shares can be evaluated.
Northrim BanCorp's "short interest ratio" (SIR) is the quantity of Northrim BanCorp shares currently shorted divided by the average quantity of Northrim BanCorp shares traded daily (recently around 17782.378854626). Northrim BanCorp's SIR currently stands at 2.27. In other words for every 100,000 Northrim BanCorp shares traded daily on the market, roughly 2270 shares are currently held short.
However Northrim BanCorp's short interest can also be evaluated against the total number of Northrim BanCorp shares, or, against the total number of tradable Northrim BanCorp shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Northrim BanCorp's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Northrim BanCorp shares in existence, roughly 10 shares are currently held short) or 0.0071% of the tradable shares (for every 100,000 tradable Northrim BanCorp shares, roughly 7 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Northrim BanCorp.
Find out more about how you can short Northrim BanCorp stock.
Dividend payout ratio: 21.94% of net profits
Recently Northrim BanCorp has paid out, on average, around 21.94% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.45% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Northrim BanCorp shareholders could enjoy a 3.45% return on their shares, in the form of dividend payments. In Northrim BanCorp's case, that would currently equate to about $1.47 per share.
While Northrim BanCorp's payout ratio might seem low, this can signify that Northrim BanCorp is investing more in its future growth.
Northrim BanCorp's most recent dividend payout was on 16 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 7 September 2021 (the "ex-dividend date").
Northrim BanCorp's shares were split on a 105:100 basis on 18 September 2007. So if you had owned 100 shares the day before before the split, the next day you'd have owned 105 shares. This wouldn't directly have changed the overall worth of your Northrim BanCorp shares – just the quantity. However, indirectly, the new 4.8% lower share price could have impacted the market appetite for Northrim BanCorp shares which in turn could have impacted Northrim BanCorp's share price.
Over the last 12 months, Northrim BanCorp's shares have ranged in value from as little as $27.0394 up to $47.3647. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Northrim BanCorp's is 0.7582. This would suggest that Northrim BanCorp's shares are less volatile than average (for this exchange).
Northrim BanCorp, Inc. operates as the bank holding company for Northrim Bank that provides commercial banking products and services to businesses and professional individuals. It operates in two segments, Community Banking and Home Mortgage Lending. The company offers noninterest-bearing checking accounts and interest-bearing time deposits, checking and savings accounts, individual retirement accounts, money market deposit accounts, and certificates of deposit. It also provides family residential mortgages; commercial loans, such as secured and unsecured loans for working capital and expansion; commercial real estate loans; construction loans for commercial real estate projects, and land development and residential subdivision construction loans; and loans for automobiles, recreational vehicles, boats, and other consumer purchases, as well as home equity and commercial credit lines, and factoring services. In addition, the company offers other services that include consumer online banking, mobile app and mobile deposit, mobile Web and text banking, business online banking, personal finance, online documents, consumer and business debit cards, home equity advantage access cards, and telebanking and automated teller services. Further, it provides personalized checks, overdraft protection from savings accounts, commercial drive-up banking, automatic transfers and payments, people pay, external and wire transfers, bill pay, direct payroll deposits, electronic tax payments, automated clearing house origination and receipt, remote deposit capture, and account reconciliation and positive pay services, as well as merchant and cash management programs, annuity products, and long term investment portfolios.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.